Chronic lithium administration alters the interaction between opiate antagonists and opiate receptors in vivo.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D008094:Lithium / Q000494:pharmacology*; D008297:Male; D008566:Membranes / Q000378:metabolism; D051379:Mice; D009270:Naloxone / Q000494:pharmacology; D009271:Naltrexone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D009619:Nociceptors / Q000187:drug effects; D011930:Reaction Time / Q000187:drug effects; D011957:Receptors, Opioid / Q000187:drug effects*; D013997:Time Factors
D009292:Narcotic Antagonists; D011957:Receptors, Opioid; D009270:Naloxone; D009271:Naltrexone; D008094:Lithium